1-20 of 26
epigenetics
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.
https://doi.org/10.1182/asheducation-2018.1.264
Published: 2018
Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.
https://doi.org/10.1182/asheducation-2018.1.63
Published: 2018
Journal Articles

How and when to decide between epigenetic therapy and chemotherapy in patients with AML

Hervé Dombret, Raphael Itzykson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 45–53.
https://doi.org/10.1182/asheducation-2017.1.45
Published: 2017
Journal Articles

Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies

Shaji Kumar
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 518–524.
https://doi.org/10.1182/asheducation-2017.1.518
Published: 2017
Journal Articles

Mutations in AML: prognostic and therapeutic implications

Courtney D. DiNardo, Jorge E. Cortes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 348–355.
https://doi.org/10.1182/asheducation-2016.1.348
Published: 2016
Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.
https://doi.org/10.1182/asheducation-2016.1.284
Published: 2016
Journal Articles

Molecularly targeted therapies for acute myeloid leukemia

Eytan M. Stein
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 579–583.
https://doi.org/10.1182/asheducation-2015.1.579
Published: 2015
Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.
https://doi.org/10.1182/asheducation-2015.1.317
Published: 2015
Journal Articles

Epigenetic targeting and personalized approaches for AML

Gail J. Roboz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 44–51.
https://doi.org/10.1182/asheducation-2014.1.44
Published: 2014
Journal Articles

The evolving genomic landscape of myeloproliferative neoplasms

Jyoti Nangalia, Tony R. Green
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 287–296.
https://doi.org/10.1182/asheducation-2014.1.287
Published: 2014
Journal Articles

Dissecting follicular lymphoma: high versus low risk

Sonali M. Smith
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 561–567.
https://doi.org/10.1182/asheducation-2013.1.561
Published: 2013
Journal Articles

Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP

Leandro Cerchietti, John P. Leonard
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 591–595.
https://doi.org/10.1182/asheducation-2013.1.591
Published: 2013
Journal Articles

Focus on the epigenome in the myeloproliferative neoplasms

Eunhee Kim, Omar Abdel-Wahab
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 538–544.
https://doi.org/10.1182/asheducation-2013.1.538
Published: 2013
Journal Articles

The molecular genetic makeup of acute lymphoblastic leukemia

Charles G. Mullighan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 389–396.
https://doi.org/10.1182/asheducation.V2012.1.389.3798360
Published: 2012
Journal Articles

New insights in the biology of Hodgkin lymphoma

Ralf Küppers
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 328–334.
https://doi.org/10.1182/asheducation.V2012.1.328.3798326
Published: 2012
Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.
https://doi.org/10.1182/asheducation.V2012.1.553.3800163
Published: 2012
Journal Articles

Interpreting new molecular genetics in myelodysplastic syndromes

Omar Abdel-Wahab, Maria E. Figueroa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 56–64.
https://doi.org/10.1182/asheducation.V2012.1.56.3798194
Published: 2012
Journal Articles

Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms

Nicholas C. P. Cross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 208–214.
https://doi.org/10.1182/asheducation-2011.1.208
Published: 2011
Journal Articles

Targeting Epigenetic Programs in MLL -Rearranged Leukemias

Kathrin M. Bernt, Scott A. Armstrong
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 354–360.
https://doi.org/10.1182/asheducation-2011.1.354
Published: 2011